Methyl 4-hydroxynicotinate

Catalog No. :
ACIZBX534
CAS No. :
67367-24-2
Molecular Formula :
C7H7NO3
Molecular Weight :
153.14

IUPAC Name:methyl 4-hydroxynicotinate

Methyl 4-hydroxynicotinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$82.00Login to see priceIn stockIn stock
10g98%$164.00Login to see priceIn stockIn stock
25g98%$408.00Login to see priceIn stockInquiry
100g98%$1324.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-hydroxynicotinate
IUPAC Namemethyl 4-hydroxynicotinate
MDL No.MFCD04114270
Molecular FormulaC7H7NO3
Molecular Weight153.14
SMILESCOC(=O)C1=C(O)C=CN=C1
InChI KeyIHBXKOZLARNEHF-UHFFFAOYSA-N
Synonym3-Pyridinecarboxylicacid,4-hydroxy-,methylester(9CI);4-HYDROXYPYRIDINE-3-CARBOXYLIC ACID METHYL ESTER;4-HYDROXY-NICOTINIC ACID METHYL ESTER;Methyl 4-hydroxynicotinate;Methyl 4-hydroxypyridine-3-carboxylate;2-methyl-4-oxo-1H-pyridine-3-carboxylate;3-PYRIDINECARBOXYLIC ACID 1,4-DIHYDRO-4-OXO-,METHYL ESTER;Methyl 4-oxo-1,4-dihydro-3-pyridinecarboxylate
CAS No.67367-24-2
PubChem CID2762945

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIZBX534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACJXQA859 route compound structure diagram
    ACJXQA859609-70-1 In Stock
  4. Then
  5. ACIZBX534 route product structure diagram
    ACIZBX53467367-24-2 In Stock
Inquiry

2. ACIZBX534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLTSI061 route compound structure diagram
    ACLTSI06110177-32-9 In Stock
  2. Then
  3. ACIZBX534 route product structure diagram
    ACIZBX53467367-24-2 In Stock
Inquiry

Comments (0)